Epidemiology of endometriosis by F. Parazzini & M. Ferraroni
Consent for surgery for
psychiatric patients
EDITOR,-Nick Kosky is right to be concerned
when surgical teams ask him, as duty psychiatrist,
to give consent for operative procedures on behalf
of psychiatric patients detained under the Mental
Health Act. Although most patients who have
been admitted on a section are perfectly capable of
deciding for themselves, the referrals that Kosky
mentions might have been justified had he instead
been asked to advise about the patients' ability to
give real consent. As Kosky points out, competence
to consent can vary with the complexity of the
factors that need to be taken into account, but,
also, competence can change from day to day
depending on the cause of the intellectual dis-
ability. In these circumstances how does a surgeon
with skills appropriate to that trade decide if a
patient's consent is valid?
In a paper on assessing patients' capacity to
consent Appelbaum and Grisso warn that im-
properly depriving a patient of his or her rights to
make decisions is a serious infringement of liberty.2
Usually the evaluation of someone's competence
presents no problem, but if doubt exists Appel-
baum and Grisso favour formal analysis. They
recommend that a third party assessor should be
present throughout the interview during which the
procedure is explained to the patient in order to
understand what has been said and to observe the
patient's responses to that information. Then,
using questions specifically designed to show
ability in four areas-to communicate a choice, to
understand the relevant information, to appreciate
the importance of the circumstances and their
consequences, and to manipulate information
rationally-the assessor should judge whether the
patient's consent is real.
Once competence, or its absence, has been
established, correct practice along the lines recom-







1 Kosky N. Consent for surgery for psychiatric patients. BMJ
1993;306:519. (20 February.)
2 Appelbaum PS, Grisso T. Assessing patients' capacity to consent
to treatment. NEngl7Med 1988;319:1635-8.
3 NHS Management Executive. A guide to consent for examination
and treatment. London: NHSME, 1990.
Population mixing and excess of
childhood leukaemia
EDITOR,-EVe Roman and colleagues observed
about 25 more cases of leukaemia and non-
Hodgkin's lymphoma than would be expected
among children aged 0-4 in West Berkshire and
North Hampshire health districts in 1972-89.1 2 We
wish to draw attention to a study that offers an
explanation for the excess.3
TABLE iI-Adjusted ratios of observed to expected cases of
leukaemia and non-Hodgkin's lymphoma at ages 0-4 in
groups of county districts by increases in population and
commuting 1971-81. * Figures in parentheses are observed
numbers ofcases
Quarters of increase in commuting
Quarters of
relative increase 1 2 3 4
in population (Lowest) (Highest)
1 (Lowest) 1 00 (34) 0 70 (14) 1-01 (9)
2 1 12(24) 1.37(28) 0 96 (19)
3 1 22(35) 094(18) 0-91(15) 1 12 (13)
4 (Highest) 1.12 (28) 0 90 (11) 175t (49)
*Four similar sized groups were forned after county districts
were ranked by increase in commuting and increase in
population.
tl 71 after exclusion of Reading (p < 0 0 1).
The incidence of childhood leukaemia can be
increased by population mixing, consistent with an
infective basis.4' Contacts among people from
different communities at work and in the course of
travel also seem relevant. A high level of com-
muting (both in and out) of many towns is now
increasingly common, and the daily number of
people crossing towns' boundaries may equal their
total population. The relevance of increases in
commuting was tested in the only 28 towns in
which accurate comparisons of workplace census
data (1971 and 1981) are possible because their
boundaries were not affected by the reorganisa-
tions of 1974.
After these 28 towns (now county districts) were
ranked by the increase in commuting a significant
trend in the incidence of leukaemia was found at
ages 0-14 (p < 0 05) and a trend at ages 0-4 (p=
0-055) over 1972-85.3 Among the 10 similar sized
groups of county districts ranked by increase in
commuting a significant increase (p < 0 01) was
present (only) in group X, with the greatest
increase in commuting; this group includes
Reading, the highest increase of all. Reading lies
entirely within the 50 wards in which the excess in
West Berkshire was concentrated,2 contributing
50% of their total population-more than any
other county district. Reading, however, is not
responsible for the excess in the highest com-
muting group, which persists after it is excluded
(table I).
Reading is far from being the only part of the two
health districts in the recent study to have
experienced unusual increases in commuting.
When the 402 county districts in England and
Wales were ranked according to increase in com-
muting the above 50 wards were found to belong to
county districts in the top 13% and also to the range
of increase in commuting of group X in the table.
These associations with an increase in commuting
may be compounded by an increase in population,
and in a combined analysis the only category to
show a significant excess of leukaemia and non-
Hodgkin's lymphoma was highest for each
measure (table II). This may have relevance to the
two districts studied by Roman and colleagues,
which include so called "Silicon Valley," Basing-
stoke and Wokingham (both expanding), and the
Earley housing development, one of the largest in
the country. Indeed, the increases in population
TABLE i-Adjusted ratios of observed to expected cases ofleukaemia and non-Hodgkin's lymphoma at ages 0-4 in groups
ofcounty districts by increase in commuting 1971-81 t
Tenth County district Observed: expected Observed No
I (Lowest) Liverpool 1 00 26
II Wolverhampton, Southend 1 41 30
III Brighton, Blackpool, Stoke 1 06 26
IV-VIII 1 03-1 24t
IX Luton, Portsmouth, York, Bath 1 21 32
X (Highest) Exeter, Ipswich, Lincoln, Gloucester, Reading 1 77** 48
(X Excluding Reading 1.70* 34)
*p < 0 05, **p < 0-01 (corrected for multiple comparisons).
tAfter county districts were ranked by increase in commuting 10 groups of similar person years at 0-14 were formed.
tNone significant; groups banded together for reasons of space.
and commuting in the six main constituent county
districts of these two health districts would place
them in the extreme category in table II.
The population mixing hypothesis is concerned
with changes in a community's levels of susceptible
and infected subjects. Nevertheless, it seems
plausible that children in families with a high level
of personal contacts may be at greater risk. Certain
occupations and workplaces and house moves are
relevant. Perhaps Roman and colleagues could
examine their data in the light of this.'
L J KINLEN
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Epidemiology ofendometriosis
EDITOR,-The study ofM P Vessey and colleagues
suggests that oral contraceptives temporarily
suppress endometriosis.' An increased risk of
ovarian endometriosis in women who had used
contraceptives was also reported in a case-control
study conducted in Italy.'
To offer further data on the issue we analysed
data collected in a case-control study conducted in
northern Italy. The general design has been
described elsewhere.3 This study does not include
cases considered in the previous Italian study.
Cases were 376 women (median age 32 years) with
laparoscopically or laparotomically confirmed
pelvic endometriosis. A total of 522 controls
(median age 33 years) were interviewed. Of these,
32% had been admitted to hospital for traumatic
conditions, 32% for non-traumatic orthopaedic
disorders, 18% for surgical conditions (mostly
abdominal, such as acute appendicitis or strangu-
lated hernia), and 17% for other illnesses, such as
ear, nose, throat, or dental disorders.
A total of 15 (4%) and 137 (36%) cases and 24
(5%) and 131 (25%) controls were, respectively,
currently using and had formerly used oral contra-
ceptives. The corresponding relative risks were 0-8
(95% confidence interval, 0 3 to 1-6) and 1 9 (1-4 to
2 6) (table). When the analysis considered sepa-
rately cases of endometriosis with sterility, pelvic
pain, or other conditions (pelvic masses or inci-
dental diagnosis of endometriosis during surgery
for other conditions, such as hysterectomy for
fibroids), the estimated relative risks were 2-3 and
2 2, respectively, for current and former uses for
women with sterility, 2-7 and 2-7 for those with
pelvic pain, and 0 7 and 1-5 for women who
underwent surgery for other reasons. No clear
relation emerged between risk of endometriosis
and duration of oral contraceptive use and recency
and latency of use.
The general findings of this analysis confirm the
evidence from Vessey and colleagues ofan increased
frequency of endometriosis in former users of oral
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Multivariate relative risk (95% confidence interval) ofpelvic endometriosis according to oral contraceptive use, northern
Italy
Indication for diagnostic surgery
Sterility Pelvic pain Othert Total series
Oral contraceptive use
Never users 1-00 1-00 1-00 1-00
(n= 67) (n= 25) (n= 131)
Currentusers 2-3 (0-1 to2 l) 2 7 (0O9to7 8) 0 7 (0-2to 1 8) 0-8 (0 3 to 1.6)
(n=) (n= 6) (n= 7)
Formerusers 2 2 (1 3 to 3 7) 2 7 (1 4 to 5 2) 1 5 (1 0 to 2 3) 1 9 (1 4 to 2 6)
(n = 53) (n = 21) (n = 63)
Duration ofuse (years):
<3 21 (1 2to32) 24(12 to 50) 1l6(1.0 to 25) 19(13 to 27)
(n = 37) (n = 18) (n = 49)
33 15(07 to 31) 32(13 to 77) 1.1(06 to 19) 14(0-9to22)
(n = 12) (n= 9) (n = 21)
Time since last use (years):
< 10 2-4 (1 4 to 4O0) 31(1 6 to 6 2) 1l5 (I 0 to 2-4) 20 (1-4 to 2 9)
(n = 46) (n = 18) (n = 42)
10 13 (04to40) 07 (01 to50) 16 (09to30) 15 (09to27)
(n =7) (n =i) (n= 21)
Time since first use (years):
<15 19(12to32) 28(15to53) 14(09to21) 17(13to24)
(n= 50) (n= 24) (n= 53)
3 15 1 4 (0 3 to 5'7) 1 3 (072 to 10 0) 1-4 (0 7 to 3-0) 1 4 (0 7 to 2 8)
(n= 4) (n = 1) (n= 13)
*Multivariate estimates adjusted for age, education, parity, and in tum the above indicators of oral contraceptive use.
tlncluding pelvic masses and incidental diagnosis.
contraceptives. Although the results for current
users were compatible with a reduced risk, the
estimate was not significant, possibly on account of'
small absolute numbers of cases. It is interesting to
note that in our study an increased risk of endo-'
metriosis for former users was evident in women in
whom diagnosis of the disease was an incidental
finding-that is, in the group in which indication
bias should have a minor role. Indication and
diagnostic bias may, however, have different roles
in different diagnostic subgroups, and it is there-
fore difficult to quantify their role.
FABIO PARAZZINI
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ED1TOR,-M P Vessey and colleagues have shown
that current use of oral contraception has a sig-
nificant protective effect (relative risk 0 4) against
endometriosis.' The relative risk in women who
had stopped taking the pill 25-48 'rsonths
previously compared with women who had never
taken the pill was 1-8. This is inadequate evidence
to propose a true worsening of the risk of endo-
metriosis as a rebound effect after the pill is
stopped. A more plausible explanation is selection
bias: the women in this non-randomised cohort
study who chose to take the pill were probably to
some extent self selected or selected by their doctor
for problems with their periods.
It has long been known that both bleeding and
pain are improved by the combined pill; hence
women with endometriosis or .women likely to
develop symptoms of the condition are likely to
have been overrepresented in the cohort taking
the pill. The endometriosis would generally not
become manifest until pill taking stopped, thus
producing a higher rate in former users than
among those who had never used the pill. If this
explanation is true, so that those taking the pill
tended to be a higher risk group, the observed
beneficial effect of current use of the pill in
suppressing symptomatic endometriosis is all the
more impressive.
Increased benefit with increasing total duration
of use of the pill was not shown in the whole
population, but this included both current and
former users. Have the authors examined whether,
among current users who have never taken a break
from the method, increasing duration of use
further improves the beneficial effect?
I agree with Eric J Thomas that the main
indication for treatment is cyclical pelvic pain and
dyspareunia.2 Because endometriosis is chronic
and relapsing, after initial medical or surgical
treatment it must be suppressed long term. The
combined pill has now been shown to be suitable
for that purpose, long term.; I also agree that these
data "support the hypothesis that the incidence of
the disease is related to exposure to menstruation."
I have, therefore, for some time recommended
maintenance treatment with the "tricycle regimen"
first introduced for a different purpose by Loudon
et al, in which three or four packets of the pill
(which should logically be a relatively oestrogen
deficient and progestogen dominant formulation)
are taken consecutively before each pill free
interval.' Although pill bleeds are hormone
withdrawal bleeds rather than menses, it seems
logical to arrange that they are infrequent, occur-
ring four or five rather than 13 times a year, to
minimise bleeding into persistent endometrial
deposits. A study in which this regimen was used
might well show an even greater protective effect.
J GUILLEBAUD
Margaret Pyke Centre for Training
in Family Planning,
London W1V 5TW
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Increasing patients' knowledge
ofsecondary contraception
EDITOR,-D R Bromham and R S V Cartmill
report the knowledge and use of secondary con-
traception among patients requesting termination
of pregnancy at a fertility control unit.' They found
that many patients had switched from using the pill
to condoms for contraception, hoping to decrease
any risk of contracting AIDS. A considerable
number of the women said that a condom had
leaked and some that one had split. The authors
concluded that an increasing proportion of un-
planned pregnancies were due to condom failure.
They also found that many women were unaware
of the availability of the postcoital pill-popularly
and perhaps misleadingly called the morning after
pill, although it is recommended for use up to 72
hours after any risk.
This exactly reflects my experience in seeing
a large number of women who have sought a
termination of pregnancy in Liverpool. I wrote to
two large manufacturers of condoms, pointed
out my findings, and suggested that it would be
helpful if they included in their product's leaflet
information about the postcoital pill, how to obtain
it, and in what circumstances to use it. This was in
July 1989, and by November I had received
considered replies from both manufacturers.
One manufacturer wrote: "To incorporate such
wording as you suggest within our instructions
would imply that the product has a higher failure
rate than is actually the case and cast doubt upon
the advisability of its use." The other, having said
that most "failures" (its inverted commas) are
really related to the users and not the product,
went on to say: "I find it hard to envisage how such
advice could be given without causing potential
damage to our own product's reputation." Manu-
facturers competing in the market may well have
a problem, but surely a form of words could
be agreed and, with government help, made
mandatory for inclusion in all manufacturers'
information sheets.
CYRIL TAYLOR
Liverpool LI 5 8JJ
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Re-emergence oftuberculosis
EDITOR,-John M Watson's editorial and M
Kennedy and colleagues' letter draw attention to
the danger of multidrug resistant tuberculosis,
particularly in HIV positive patients.'2 We have
completed a bacteriological survey of tuberculosis
in south east England from 1984 to 1991.3 This
survey included a study of the prevalence of drug
resistance in different ethnic groups. The table
summarises the findings, which may prove useful
for comparative purposes in future surveys. The
overall distribution of resistance was not signi-
Prevalence of tuberculosis due to drug resistant strains
of Mycobacterium tuberculosis in south east England,
1984-91
Ethnic origin of patients
Indian
European subcontinent Other
Type of resistance (n= 4594) (n = 4099) (n = 625)
1 Drug:
Isoniazid 60 119 16
Streptomycin 30 72 21
Pyrazinamide 15 12 2




streptomycin 16 83 22
Isoniazid and
rifampicin 4 4 4
Other 1 7
3 Drugs 1 28 1
4 Drugs 1 14 5
5 Drugs 1 3 1
6 Drugs 1
Total (%) resistant 133 (2 9) 348 (8 5) 73* (1 1 7)
*35 African, 31 from Far East, seven other.
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